The goal of this study was to show that quantifiable metabolic changes may be used to screen for cancer. NIH III nude mice (n=22) were injected with human GBM cells, with daily urine samples collected pre and post-injection. 14 mice were injected with saline to serve as controls. The measurement of metabolite concentrations took place on an 800 MHz NMR spectrometer. 34 metabolites were identified and quantified, through targeted profiling, with Chenomx Suite 5.1. Univariate statistical analysis showed that 3 metabolites (2-oxoglutarate, glucose and trimethylamine n-oxide) were significantly altered in the presence of tumour, while PCA and PLS-DA models found the maximum variance between the healthy and tumour-bearing groups. Receiver operating characteristic (ROC) curve analysis was applied to the data set to provide a measure of clinical utility. ROC statistics were as high as 0.85 for the analysis of individual metabolites, 0.939 for the analysis of metabolite pairs and 0.996 for PLS-DA models. These results show that metabolomics has potential as a screening tool for cancer. / Medical Physics
| Identifer | oai:union.ndltd.org:LACETR/oai:collectionscanada.gc.ca:AEU.10048/1561 |
| Date | 11 1900 |
| Creators | Moroz, Jennifer |
| Contributors | Gino Fallone (Oncology), Alasdair Syme (Oncology), Keith Wachowicz (Oncology), Nicola De Zanche (Oncology), Jack Tuszynski (Physics) |
| Source Sets | Library and Archives Canada ETDs Repository / Centre d'archives des thèses électroniques de Bibliothèque et Archives Canada |
| Language | English |
| Detected Language | English |
| Type | Thesis |
| Format | 1928538 bytes, application/pdf |
Page generated in 0.0017 seconds